{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1299746", "DateCompleted": {"Year": "1993", "Month": "05", "Day": "14"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0021-4868", "JournalIssue": {"Volume": "33", "Issue": "6", "PubDate": {"Year": "1992", "Month": "Nov"}}, "Title": "Japanese heart journal", "ISOAbbreviation": "Jpn Heart J"}, "ArticleTitle": "Effects of a new antiarrhythmic drug, SD-3212, on canine ventricular arrhythmia models.", "Pagination": {"StartPage": "851", "EndPage": "861", "MedlinePgn": "851-61"}, "Abstract": {"AbstractText": ["The antiarrhythmic effects of a new antiarrhythmic agent, SD-3212, (-)-(S)-3,4-Dihydro-2-[5-methoxy-2-[3-[N-methyl-N-[2-[(3,4- methylene dioxy)phenoxy]ethyl]amino]propoxy]phenyl]-4-methyl-3-oxo-2H-1, 4-benzothiazine hydrogen fumarate, were investigated using canine models of ventricular arrhythmias, i.e. spontaneously occurring digitalis-, two-stage coronary ligation- and adrenaline-induced arrhythmias. SD-3212 suppressed adrenaline-induced arrhythmia and showed some antiarrhythmic effect on digitalis- and 48 hr coronary ligation-arrhythmias. These results indicate that SD-3212 has antiarrhythmic effects common among class IV antiarrhythmic drugs and also has additional efficacy common among class I antiarrhythmic drugs, thus when considering the level of experimental arrhythmias it somewhat resembles propafenone. It may therefore become a clinically useful antiarrhythmic drug among typical class I or class IV antiarrhythmic drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yamanashi Medical College, Japan."}], "LastName": "Hirasawa", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Haruno", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Matsuzaki", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hashimoto", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Jpn Heart J", "NlmUniqueID": "0401175", "ISSNLinking": "0021-4868"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazoles"}, {"RegistryNumber": "DGN08QZ30G", "NameOfSubstance": "sesamodil"}, {"RegistryNumber": "YKH834O4BH", "NameOfSubstance": "Epinephrine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": ["chemically induced", "etiology", "physiopathology"], "DescriptorName": "Arrhythmias, Cardiac"}, {"QualifierName": [], "DescriptorName": "Coronary Vessels"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Epinephrine"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Ligation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Osmolar Concentration"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["blood", "pharmacology"], "DescriptorName": "Thiazoles"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "11", "Day": "1"}, {"Year": "1992", "Month": "11", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1299746", "10.1536/ihj.33.851"]}}]}